Key facts
- This page summarizes Andrew Hotsko's Form 5 filing for CitroTech Inc. (CITR).
- 3 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 24 Feb 2026, 16:43.
Key filing fact
Ownership activity is grounded in SEC Form 5 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Other
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
Purchase
Purchase
Additional SEC filing notes
Footnote F1
The securities reported in Column 5 of Table I are restricted stock units ("RSU"). Each RSU represents a contingent right to receive one share of common stock, subject to the applicable vesting schedule and conditions of the applicable RSU award. The 150,000 RSUs reported in Column 5 vest in equal quarterly installments and are scheduled to vest in full on June 27, 2029, subject to the reporting person's continued service with the Issuer through each applicable vesting date.
Footnote F2
Each share of Series C Convertible Preferred Stock is convertible at any time and from time to time at the option of the holder into 3.3333 shares of common stock, par value $0.0001 per share, of the Issuer. The Series C Convertible Preferred Stock has no expiration date.
Footnote F3
On September 30, 2025, the reporting person entered into a securities purchase agreement (the "Securities Purchase Agreement") with the Issuer, pursuant to which the reporting person purchased 3,334 shares of Series C Convertible Preferred Stock (the "Series C Shares") for an aggregate purchase price of $50,010 ($15.00 per Series C Share).
Footnote F4
The Warrant is exercisable at any time by the reporting person prior to its expiration.
Footnote F5
In connection with the execution of the Securities Purchase Agreement, the reporting person also executed a common stock purchase warrant agreement (the "Warrant Agreement"), pursuant to which the Issuer issued a warrant to the reporting person. The Warrant Agreement entitles the reporting person to purchase from the Issuer up to 50% of the number of shares of Common Stock issuable upon full conversion of all the Series C Shares purchased by the Reporting Person, subject to the terms and conditions of the Warrant Agreement.
SEC remarks
All figures reflect the Issuer's 1-for-6 reverse stock split effective August 27, 2025.